Lentigines in resolving psoriatic plaques: rarely reported sequelae in pediatric cases

Caroline L LaRosa; Galen T Foulke; Dana F Feigenbaum; Kelly M Cordoro; Andrea L Zaenglein

doi:10.1111/pde.12543

Lentigines in resolving psoriatic plaques: rarely reported sequelae in pediatric cases

Pediatr Dermatol. 2015 May-Jun;32(3):e114-7. doi: 10.1111/pde.12543. Epub 2015 Feb 26.

Authors

Caroline L LaRosa¹, Galen T Foulke², Dana F Feigenbaum³, Kelly M Cordoro^{4

5}, Andrea L Zaenglein^{2

6}

Affiliations

¹ Penn State College of Medicine, Pennsylvania State University, Hershey, Pennsylvania.
² Department of Dermatology, Hershey Medical Center, Pennsylvania State University, Hershey, Pennsylvania.
³ School of Medicine, University of California at San Diego, San Diego, California.
⁴ Department of Dermatology, University of California at San Francisco, San Francisco, California.
⁵ Department of Pediatrics, University of California at San Francisco, San Francisco, California.
⁶ Department of Pediatrics, Hershey Medical Center, Pennsylvania State University, Hershey, Pennsylvania.

PMID: 25727728
DOI: 10.1111/pde.12543

Abstract

Lentigo formation has been described in adults after the resolution of psoriatic plaques treated with various standard psoriasis treatments. We describe three cases of lentigines developing in areas of resolving psoriatic plaques: two in patients treated with etanercept and one before starting etanercept. A possible pathomechanism is proposed.

Publication types

Case Reports

MeSH terms

Adolescent
Child
Clobetasol / therapeutic use
Etanercept / therapeutic use
Female
Glucocorticoids / therapeutic use
Humans
Immunosuppressive Agents / therapeutic use
Lentigo / etiology*
Male
Psoriasis / complications*
Psoriasis / drug therapy*

Substances

Glucocorticoids
Immunosuppressive Agents
Clobetasol
Etanercept